​
Login / Signup

Lore Spiessens

ORCID

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 1
20252016

Top Topics

20252016
Heat Shock
20252016
Mouse Model
20252016
Hiv Testing
20252016
Lps Induced

Top Venues

Molecular cancer therapeutics
This page only lists publications with an associated author ORCID identifier.
Publications
  • Hanne Hillen, Aurelie Candi, Bart Vanderhoydonck, Weronika Kowalczyk, Leticia Sansores-García, Elena C Kesikiadou, Leen Van Huffel, Lore Spiessens, Marnik Nijs, Erik Soons, Wanda Haeck, Hugo Klaassen, Wim Smets, Stéphane A Spieser, Arnaud Marchand, Patrick Chaltin, Fabrice Ciesielski, Francois Debaene, Lei Chen, Adeela Kamal, Stephen L Gwaltney, Matthias Versele, Georg A Halder
    A novel irreversible TEAD inhibitor, SWTX-143, blocks Hippo pathway transcriptional output and causes tumor regression in preclinical mesothelioma models. Molecular cancer therapeutics (2023)